| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Experimental Oncology [D. N. S., J. E. S., B. L.], Hematology/Oncology [D. N. S.], Pathology [J. R. D.], Tumor Cell Biology [J. R. D.], and Virology and Molecular Biology [C. W. N.], St. Jude Children's Research Hospital, Memphis, Tennessee 38105, and Departments of Pediatrics [D. N. S.] and Pathology [J. R. D., C. W. N.], University of Tennessee College of Medicine, Memphis, Tennessee 38163
Alveolar rhabdomyosarcoma, a malignant tumor of skeletal muscle, is characterized by a chromosomal translocation, t(2;13)(q35;q14). This translocation is associated with a structural rearrangement of the gene encoding PAX3, a presumed transcriptional regulator expressed exclusively during embryogenesis. The breakpoint results in a fusion between PAX3 and a gene provisionally named ALV, a novel member of the forkhead family of transcription factors. In PAX3-ALV, the structural integrity of both PAX3 DNA-binding regions, the paired box and homeodomain, are retained while the putative transcriptional activation domain of PAX3 is replaced by the bisected forkhead DNA-binding domain of ALV. Formation of chimeric transcription factors has now been implicated in diverse human tumors of myogenic, hematopoietic, neuroectodermal, and adipocytic origin, suggesting that transcriptional deregulation is a common mechanism of tumorigenesis.
1 Supported in part by Grant CA-23099 and Cancer Center CORE Grant CA-21765 from the NIH and by the American Lebanese Syrian Associated Charities (ALSAC).
2 To whom requests for reprints should be addressed, at the Department of Experimental Oncology, St. Jude Children's Research Hospital, 332 North Lauderdale, Memphis, TN 38105.
Received 9/29/93. Accepted 10/ 1/93.
This article has been cited by other articles:
![]() |
G. N. Corry, M. J. Hendzel, and D. A. Underhill Subnuclear localization and mobility are key indicators of PAX3 dysfunction in Waardenburg syndrome Hum. Mol. Genet., June 15, 2008; 17(12): 1825 - 1837. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.J. Sebire and M. Dixon-Woods Towards a new era of tissue-based diagnosis and research Chronic Illness, December 1, 2007; 3(4): 301 - 309. [Abstract] [PDF] |
||||
![]() |
C. M. Linardic, S. Naini, J. E. Herndon II, C. Kesserwan, S. J. Qualman, and C. M. Counter The PAX3-FKHR Fusion Gene of Rhabdomyosarcoma Cooperates with Loss of p16INK4A to Promote Bypass of Cellular Senescence Cancer Res., July 15, 2007; 67(14): 6691 - 6699. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Delpuech, B. Griffiths, P. East, A. Essafi, E. W.-F. Lam, B. Burgering, J. Downward, and A. Schulze Induction of Mxi1-SR{alpha} by FOXO3a Contributes to Repression of Myc-Dependent Gene Expression Mol. Cell. Biol., July 1, 2007; 27(13): 4917 - 4930. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Taulli, C. Scuoppo, F. Bersani, P. Accornero, P. E. Forni, S. Miretti, A. Grinza, P. Allegra, M. Schmitt-Ney, T. Crepaldi, et al. Validation of Met as a Therapeutic Target in Alveolar and Embryonal Rhabdomyosarcoma. Cancer Res., May 1, 2006; 66(9): 4742 - 4749. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Croci, L. Landuzzi, A. Astolfi, G. Nicoletti, A. Rosolen, F. Sartori, M. Y. Follo, N. Oliver, C. De Giovanni, P. Nanni, et al. Inhibition of Connective Tissue Growth Factor (CTGF/CCN2) Expression Decreases the Survival and Myogenic Differentiation of Human Rhabdomyosarcoma Cells Cancer Res., March 1, 2004; 64(5): 1730 - 1736. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Kutko, R. D. Glick, L. M. Butler, D. C. Coffey, R. A. Rifkind, P. A. Marks, V. M. Richon, and M. P. LaQuaglia Histone Deacetylase Inhibitors Induce Growth Suppression and Cell Death in Human Rhabdomyosarcoma in Vitro Clin. Cancer Res., November 15, 2003; 9(15): 5749 - 5755. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. T. Burgering and R. H. Medema Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty J. Leukoc. Biol., June 1, 2003; 73(6): 689 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
N J Sebire and M Malone Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas J. Clin. Pathol., June 1, 2003; 56(6): 412 - 416. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Thyagarajan, S. Totey, M. J. S. Danton, and A. B. Kulkarni GENETICALLY ALTERED MOUSE MODELS: THE GOOD, THE BAD, ANDTHE UGLY Crit. Rev. Oral. Biol. Med., May 1, 2003; 14(3): 154 - 174. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tran, A. Brunet, E. C. Griffith, and M. E. Greenberg The Many Forks in FOXO's Road Sci. Signal., March 4, 2003; 2003(172): re5 - re5. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Xue and M. Noll Dual role of the Pax gene paired in accessory gland development of Drosophila Development, March 3, 2003; 129(2): 339 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang and C. Wang PAX3-FKHR Transformation Increases 26 S Proteasome-dependent Degradation of p27Kip1, a Potential Role for Elevated Skp2 Expression J. Biol. Chem., January 3, 2003; 278(1): 27 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Armoni, M. J. Quon, G. Maor, S. Avigad, D. N. Shapiro, C. Harel, D. Esposito, Y. Goshen, I. Yaniv, and E. Karnieli PAX3/Forkhead Homolog in Rhabdomyosarcoma Oncoprotein Activates Glucose Transporter 4 Gene Expression in Vivo and in Vitro J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5312 - 5324. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Jaboin, J. Wild, H. Hamidi, C. Khanna, C. J. Kim, R. Robey, S. E. Bates, and C. J. Thiele MS-27-275, an Inhibitor of Histone Deacetylase, Has Marked in Vitro and in Vivo Antitumor Activity against Pediatric Solid Tumors Cancer Res., November 1, 2002; 62(21): 6108 - 6115. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Lagutina, S. J. Conway, J. Sublett, and G. C. Grosveld Pax3-FKHR Knock-In Mice Show Developmental Aberrations but Do Not Develop Tumors Mol. Cell. Biol., October 15, 2002; 22(20): 7204 - 7216. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Cummings, N. M. Brown, and T. T. Stenzel TaqMan Junction Probes and the Reverse Transcriptase Polymerase Chain Reaction: Detection of Alveolar Rhabdomyosarcoma, Synovial Sarcoma, and Desmoplastic Small Round Cell Tumor Ann. Clin. Lab. Sci., July 1, 2002; 32(3): 219 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Christian, X. Zhang, T. Schneider-Merck, T. G. Unterman, B. Gellersen, J. O. White, and J. J. Brosens Cyclic AMP-induced Forkhead Transcription Factor, FKHR, Cooperates with CCAAT/Enhancer-binding Protein beta in Differentiating Human Endometrial Stromal Cells J. Biol. Chem., May 31, 2002; 277(23): 20825 - 20832. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Dilling, G. S. Germain, L. Dudkin, A. L. Jayaraman, X. Zhang, F. C. Harwood, and P. J. Houghton 4E-binding Proteins, the Suppressors of Eukaryotic Initiation Factor 4E, Are Down-regulated in Cells with Acquired or Intrinsic Resistance to Rapamycin J. Biol. Chem., April 12, 2002; 277(16): 13907 - 13917. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Pani, M. Horal, and M. R. Loeken Rescue of neural tube defects in Pax-3-deficient embryos by p53 loss of function: implications for Pax-3- dependent development and tumorigenesis Genes & Dev., March 15, 2002; 16(6): 676 - 680. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Worley, L. T. van den Broeke, T. J. Goletz, C. D. Pendleton, E. M. Daschbach, E. K. Thomas, F. M. Marincola, L. J. Helman, and J. A. Berzofsky Antigenicity of Fusion Proteins from Sarcoma-associated Chromosomal Translocations Cancer Res., September 1, 2001; 61(18): 6868 - 6875. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Anderson, A. Ramsay, S. Gould, and K. Pritchard-Jones PAX3-FKHR Induces Morphological Change and Enhances Cellular Proliferation and Invasion in Rhabdomyosarcoma Am. J. Pathol., September 1, 2001; 159(3): 1089 - 1096. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nakamura, S. Ramaswamy, F. Vazquez, S. Signoretti, M. Loda, and W. R. Sellers Forkhead Transcription Factors Are Critical Effectors of Cell Death and Cell Cycle Arrest Downstream of PTEN Mol. Cell. Biol., December 1, 2000; 20(23): 8969 - 8982. [Abstract] [Full Text] |
||||
![]() |
T. G. Kroll, P. Sarraf, L. Pecciarini, C.-J. Chen, E. Mueller, B. M. Spiegelman, and J. A. Fletcher PAX8-PPARgamma 1 Fusion in Oncogene Human Thyroid Carcinoma Science, August 25, 2000; 289(5483): 1357 - 1360. [Abstract] [Full Text] |
||||
![]() |
W. L. Gerald A Practical Approach to the Differential Diagnosis of Small Round Cell Tumors of Infancy Using Recent Scientific and Technical Advances International Journal of Surgical Pathology, April 1, 2000; 8(2): 87 - 97. [Abstract] [PDF] |
||||
![]() |
Y. Cao and C. Wang The COOH-terminal Transactivation Domain Plays a Key Role in Regulating the in Vitro and in Vivo Function of Pax3 Homeodomain J. Biol. Chem., March 24, 2000; 275(13): 9854 - 9862. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Dias, B. Chen, B. Dilday, H. Palmer, H. Hosoi, S. Singh, C. Wu, X. Li, J. Thompson, D. Parham, et al. Strong Immunostaining for Myogenin in Rhabdomyosarcoma Is Significantly Associated with Tumors of the Alveolar Subclass Am. J. Pathol., February 1, 2000; 156(2): 399 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Epstein, J Li, D Lang, F Chen, C. Brown, F Jin, M. Lu, M Thomas, E Liu, A Wessels, et al. Migration of cardiac neural crest cells in Splotch embryos Development, January 5, 2000; 127(9): 1869 - 1878. [Abstract] [PDF] |
||||
![]() |
B. E. Kempf and P. K. Vogt A Genetic Analysis of PAX3-FKHR, the Oncogene of Alveolar Rhabdomyosarcoma Cell Growth Differ., December 1, 1999; 10(12): 813 - 818. [Abstract] [Full Text] |
||||
![]() |
J. Khan, M. L. Bittner, L. H. Saal, U. Teichmann, D. O. Azorsa, G. C. Gooden, W. J. Pavan, J. M. Trent, and P. S. Meltzer cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene PNAS, November 9, 1999; 96(23): 13264 - 13269. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Wolden, J. R. Anderson, W. M. Crist, J. C. Breneman, M. D. Wharam Jr, E. S. Wiener, S. J. Qualman, and S. S. Donaldson Indications for Radiotherapy and Chemotherapy After Complete Resection in Rhabdomyosarcoma: A Report From the Intergroup Rhabdomyosarcoma Studies I to III J. Clin. Oncol., November 1, 1999; 17(11): 3468 - 3475. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A.S. Arndt and W. M. Crist Common Musculoskeletal Tumors of Childhood and Adolescence N. Engl. J. Med., July 29, 1999; 341(5): 342 - 352. [Full Text] [PDF] |
||||
![]() |
R. Dagher and L. Helman Rhabdomyosarcoma: An Overview Oncologist, February 1, 1999; 4(1): 34 - 44. [Abstract] [Full Text] |
||||
![]() |
J Li, K. Liu, F Jin, M. Lu, and J. Epstein Transgenic rescue of congenital heart disease and spina bifida in Splotch mice Development, January 6, 1999; 126(11): 2495 - 2503. [Abstract] [PDF] |
||||
![]() |
H Amthor, B Christ, and K Patel A molecular mechanism enabling continuous embryonic muscle growth - a balance between proliferation and differentiation Development, January 2, 1999; 126(5): 1041 - 1053. [Abstract] [PDF] |
||||
![]() |
P. Y. P. Lam, J. E. Sublett, A. D. Hollenbach, and M. F. Roussel The Oncogenic Potential of the Pax3-FKHR Fusion Protein Requires the Pax3 Homeodomain Recognition Helix but Not the Pax3 Paired-Box DNA Binding Domain Mol. Cell. Biol., January 1, 1999; 19(1): 594 - 601. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cederberg, M. Hulander, P. Carlsson, and S. Enerback The Kidney-expressed Winged Helix Transcription Factor FREAC-4 Is Regulated by Ets-1. A POSSIBLE ROLE IN KIDNEY DEVELOPMENT J. Biol. Chem., January 1, 1999; 274(1): 165 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tell, A. Scaloni, L. Pellizzari, S. Formisano, C. Pucillo, and G. Damante Redox Potential Controls the Structure and DNA Binding Activity of the Paired Domain J. Biol. Chem., September 25, 1998; 273(39): 25062 - 25072. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Phelan and M. R. Loeken Identification of a New Binding Motif for the Paired Domain of Pax-3 and Unusual Characteristics of Spacing of Bipartite Recognition Elements on Binding and Transcription Activation J. Biol. Chem., July 24, 1998; 273(30): 19153 - 19159. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Epstein, B. Song, M. Lakkis, and C. Wang Tumor-Specific PAX3-FKHR Transcription Factor, but Not PAX3, Activates the Platelet-Derived Growth Factor Alpha Receptor Mol. Cell. Biol., July 1, 1998; 18(7): 4118 - 4130. [Abstract] [Full Text] |
||||
![]() |
A. Llombart-Bosch, A. Peydro-Olaya, C. Carda, C. Lopez-Gines, J. Boix-Ferrero, and A. Pellin Primary Rhabdomyosarcoma Mimicking a Small Cell Sarcoma of Bone: A Nude Mice Xenograft, Cytogenetic, and Molecular Approach International Journal of Surgical Pathology, April 1, 1998; 6(2): 61 - 71. [Abstract] [PDF] |
||||
![]() |
G. J. Pelletier, S. L. Brody, H. Liapis, R. A. White, and B. P. Hackett A human forkhead/winged-helix transcription factor expressed in developing pulmonary and renal epithelium Am J Physiol Lung Cell Mol Physiol, March 1, 1998; 274(3): L351 - L359. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Davis and F. G. Barr Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene-specific mechanisms in alveolar rhabdomyosarcoma PNAS, July 22, 1997; 94(15): 8047 - 8051. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bernasconi, A. Remppis, W. J. Fredericks, F. J. Rauscher III, and B. W. Schafer Induction of apoptosis in rhabdomyosarcoma cells through down-regulation of PAX proteins PNAS, November 12, 1996; 93(23): 13164 - 13169. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sutton, R. Costa, M. Klug, L. Field, D. Xu, D. A. Largaespada, C. F. Fletcher, N. A. Jenkins, N. G. Copeland, M. Klemsz, et al. Genesis, a Winged Helix Transcriptional Repressor with Expression Restricted to Embryonic Stem Cells J. Biol. Chem., September 20, 1996; 271(38): 23126 - 23133. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ernstsson, S. Pierrou, M. Hulander, A. Cederberg, M. Hellqvist, P. Carlsson, and S. Enerback Characterization of the Human Forkhead Gene FREAC-4. EVIDENCE FOR REGULATION BY WILMS' TUMOR SUPPRESSOR GENE (WT-1) AND p53 J. Biol. Chem., August 30, 1996; 271(35): 21094 - 21099. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hellqvist, M. Mahlapuu, L. Samuelsson, S. Enerbäck, and P. Carlsson Differential Activation of Lung-specific Genes by Two Forkhead Proteins, FREAC-1 and FREAC-2 J. Biol. Chem., February 23, 1996; 271(8): 4482 - 4490. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Epstein, P. Lam, L. Jepeal, R. L. Maas, and D. N. Shapiro Pax3 Inhibits Myogenic Differentiation of Cultured Myoblast Cells J. Biol. Chem., May 19, 1995; 270(20): 11719 - 11722. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kataoka, K. Yoshitomo-Nakagawa, S. Shioda, and M. Nishizawa A Set of Hox Proteins Interact with the Maf Oncoprotein to Inhibit Its DNA Binding, Transactivation, and Transforming Activities J. Biol. Chem., January 5, 2001; 276(1): 819 - 826. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Schuur, A. V. Loktev, M. Sharma, Z. Sun, R. A. Roth, and R. J. Weigel Ligand-dependent Interaction of Estrogen Receptor-alpha with Members of the Forkhead Transcription Factor Family J. Biol. Chem., August 31, 2001; 276(36): 33554 - 33560. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. BRAR, S. HANDWERGER, C. A. KESSLER, and B. J. ARONOW Gene induction and categorical reprogramming during in vitro human endometrial fibroblast decidualization Physiol Genomics, December 21, 2001; 7(2): 135 - 148. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |